1. Home
  2. AMBO vs CYCN Comparison

AMBO vs CYCN Comparison

Compare AMBO & CYCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMBO
  • CYCN
  • Stock Information
  • Founded
  • AMBO 2000
  • CYCN 2018
  • Country
  • AMBO United States
  • CYCN United States
  • Employees
  • AMBO N/A
  • CYCN N/A
  • Industry
  • AMBO Other Consumer Services
  • CYCN Biotechnology: Pharmaceutical Preparations
  • Sector
  • AMBO Real Estate
  • CYCN Health Care
  • Exchange
  • AMBO Nasdaq
  • CYCN Nasdaq
  • Market Cap
  • AMBO 7.2M
  • CYCN 8.4M
  • IPO Year
  • AMBO 2010
  • CYCN N/A
  • Fundamental
  • Price
  • AMBO $2.43
  • CYCN $3.36
  • Analyst Decision
  • AMBO
  • CYCN
  • Analyst Count
  • AMBO 0
  • CYCN 0
  • Target Price
  • AMBO N/A
  • CYCN N/A
  • AVG Volume (30 Days)
  • AMBO 128.6K
  • CYCN 5.8M
  • Earning Date
  • AMBO 12-30-2024
  • CYCN 03-04-2025
  • Dividend Yield
  • AMBO N/A
  • CYCN N/A
  • EPS Growth
  • AMBO N/A
  • CYCN N/A
  • EPS
  • AMBO N/A
  • CYCN N/A
  • Revenue
  • AMBO $7,839,000.00
  • CYCN $194,000.00
  • Revenue This Year
  • AMBO N/A
  • CYCN N/A
  • Revenue Next Year
  • AMBO N/A
  • CYCN N/A
  • P/E Ratio
  • AMBO N/A
  • CYCN N/A
  • Revenue Growth
  • AMBO N/A
  • CYCN N/A
  • 52 Week Low
  • AMBO $1.00
  • CYCN $1.27
  • 52 Week High
  • AMBO $6.30
  • CYCN $9.47
  • Technical
  • Relative Strength Index (RSI)
  • AMBO 51.15
  • CYCN 49.03
  • Support Level
  • AMBO $2.41
  • CYCN $2.81
  • Resistance Level
  • AMBO $2.80
  • CYCN $4.80
  • Average True Range (ATR)
  • AMBO 0.32
  • CYCN 0.75
  • MACD
  • AMBO -0.01
  • CYCN -0.00
  • Stochastic Oscillator
  • AMBO 47.78
  • CYCN 26.84

About AMBO Ambow Education Holding Ltd.

Ambow Education Holding Ltd is a provider of educational and career enhancement services in China. It operates through CP&CE Programs. The CP&CE Programs include tutoring services and career enhancement services. Geographically all the operations function in the United States and Foreign countries.

About CYCN Cyclerion Therapeutics Inc.

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.

Share on Social Networks: